Entrada Therapeutics, Inc. (TRDA)
NASDAQ·Healthcare·Biotechnology
$6.88
+5.69%
Mkt Cap $274.46M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (7 analysts)
$17.00
Range $10.00 – $21.00
Implied Upside
+147.1%
Consensus $17.00 vs current $6.88
NASDAQ·Healthcare·Biotechnology
$6.88
+5.69%
Mkt Cap $274.46M
Buy
2
Hold
1
Sell
0
Price Target (7 analysts)
$17.00
Range $10.00 – $21.00
+147.1%
Consensus $17.00 vs current $6.88